StemCells Inc. (Nasdaq: STEM)
StemCells Inc. (STEM) is a clinical-stage biotechnology company, focused on the research, development and commercialization of products derived from stem-cell technologies. It targets the development of cell-based therapeutics to treat diseases of the central nervous system and liver. The Company’s lead product candidate, HuCNS-SC cells, are purified human neural stem cells, which can be expanded and banked until they are delivered as patient doses. Read more
Popularity: unranked [?]
